Veselības projekti Latvijai

Public conference "Access to Medicines in the Baltics: Changing the Narrative"

October 13, 2017 | Albert Hotel, Riga, Dzirnavu street 33

----------------

Conference Agenda

8.30 – 9.00 Registration

9.00 – 9.05 Welcoming Remarks

----------------

Part I

9.05 – 9.30 Keynote Address

Yannis Natsis | Policy Manager for Universal Access & Affordable Medicines, European Public Health Alliance (EPHA)

9.30 – 11.00 Panel session: Political Developments in Access to Medicines Debate in Europe. Where We Are and What Can be Done

- Raf Mertens | General Director, Belgian Health Care Knowledge Centre

- Erki Laidmae | Head of Insurance Benefit Package, Estonian Health Insurance Fund

- Representative of MoH of Latvia (TBC)

Moderator: Yannis Natsis

11.00-11.30 Coffee break

----------------

Part II

11.30 - 12.00 Keynote Address

Beate Wieseler | Institute for Quality and Efficiency in Health Care in Germany (IQWiG)

12.00 - 12.15 Case study

Availability of oncology drugs in the Baltics | Alessandra Ferrario, Harvard Medical School

12.15 – 13.45 Panel session: The Future of Health Technology Assessment in Europe

- Ancel.la Santos | Health Action International

- Juris Bārzdiņš | University of Latvia

- Representative of Lithuania (TBC)

Moderator – Alessandra Ferrario

13.45 – 14.45 Lunch

----------------

Part III

14.45 – 15.15 Keynote Address

Ellen 't Hoen | public health advocate, LLM, Medicines Law & Policy/ Global Health Unit – University Medical Center Groningen

15.15 – 15.30 Case Study

C hepatitis case study in Latvia. Lessons learned. Are we ready for the next Sovaldi? | Elita Poplavska & Anda Ķīvīte, Health Projects for Latvia

15.30 – 16.45 Panel session: Private patents and public health. Changing Intellectual Property Rules for Access to Medicines

- Antons Mozalevskis | WHO, specialist in epidemiology and infectious diseases

- Signe Mežinska | Health Projects for Latvia

- Ēriks Eisaks | formerly infected with Hepatitis C, has undergone two Hep C therapy courses

Moderator – Tim Reed, Health Action International (TBC)

16.45 – 17.00 End-notes and conclusion